Showing results (501-510 of 542) with videos related to

Sort By:
Pageof 55
Human Genetics|May 1, 1992
The polymorphism ApoB/4311 in patients with myocardial infarction and controls: the ECTIM StudyJ F Moreel, G Roizes, A E Evans, et al.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Journal of Immunological Methods|September 24, 1987
A monoclonal antibody (BIP 45) detects Ag(c,g) polymorphism of human apolipoprotein BP Duriez, R Butler, M J Tikkanen, et al.
Free Radical Biology & Medicine|June 9, 2004
Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteinsC Furman, A-K Rundlöf, G Larigauderie, et al.
Blood|April 27, 1999
Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alphaM Kockx, P P Gervois, P Poulain, et al.
The Journal of Biological Chemistry|July 19, 1996
Expression and regulation of the lipoprotein lipase gene in human adrenal cortexB Staels, G Martin, M Martinez, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Metabolism: Clinical and Experimental|April 1, 1994
Evidence of non-deficient low-density lipoprotein receptor patients in a pool of subjects with clinical familial hypercholesterolemia profileS Lestavel-Delattre, S Benhamamouch, G Agnani, et al.
The Journal of Endocrinology|September 1, 1999
Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cellsM Lefebvre, B Paulweber, L Fajas, et al.
Journal of Cardiovascular Pharmacology|August 7, 2001
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient miceF Dol, G Martin, B Staels, et al.
Pageof 55